Abstract
A novel Z-scheme CaF2:Yb3+,Er3+@ZnTiO3/Au/CdS photocatalyst has been prepared. In this system, an excellent up-conversion luminescent agent, CaF2:Yb3+,Er3+, is introduced to broaden the light response range. The Au surface plasmon resonance effect endows the system with highly efficient charge transfer. The photocatalytic activity of the Z-scheme CaF2:Yb3+,Er3+@ZnTiO3/Au/CdS photocatalyst has been evaluated in the degradation of norfloxacin (NOR) with simultaneous hydrogen production. Some influencing factors, such as solar light irradiation time, sacrificial agent concentration, and number of reuse cycles, are discussed. The emission spectrum and energy conversion mechanism of CaF2:Yb3+,Er3+ have also been studied. The prepared photocatalyst facilitated a significant degree of degradation (92.05%) of NOR and considerable hydrogen production (513.39 μmol/g) under solar light irradiation for 5.0 h. Moreover, it showed high stability in photocatalytic NOR degradation with simultaneous hydrogen production over five cycles. A possible mechanism for photocatalytic degradation of NOR with simultaneous hydrogen production promoted by the Z-scheme CaF2:Yb3+,Er3+@ZnTiO3/Au/CdS photocatalyst is proposed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.